Trials / Recruiting
RecruitingNCT04654208
Swedish Ibrance Registries Insights (SIRI)
Palbociclib Treatment Patterns in Swedish Patients With Metastatic Breast Cancer - Swedish Ibrance Registries Insights (SIRI)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (estimated)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objectives of this study are to describe patient characteristics, treatment patterns and clinical outcomes of patients receiving palbociclib in Swedish clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | palbociclib | patients on palbociclib combination treatment |
Timeline
- Start date
- 2020-12-15
- Primary completion
- 2026-05-31
- Completion
- 2026-05-31
- First posted
- 2020-12-04
- Last updated
- 2026-03-31
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT04654208. Inclusion in this directory is not an endorsement.